2022 annual financial data
Fulcrum Therapeutics 2022 Operating margin
Fulcrum Therapeutics 2022 operating margin with verified reported values.
Direct answer
Operating margin was -1,774.85%.
Operating income was -112,561,000 USD and net income was -109,871,000 USD.
Operating cash flow was -97,050,000 USD.
Get free Fulcrum Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 6,342,000 USD
- Operating income
- -112,561,000 USD
- Net income
- -109,871,000 USD
- Operating cash flow
- -97,050,000 USD